Berkshire Biomedical Corp — Form C-U (Regulation Crowdfunding)
Berkshire Biomedical Corp of DALLAS, TX filed a Form C-U (Regulation Crowdfunding) with the SEC on 2025-05-12. Target raise $20K, up to $1.5M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-05-12
- Form: C-U
- Accession: 0001665160-25-001065
- Target amount: $20K
- Maximum amount: $1.5M
- Security type: Other
- Securities offered: 2,500
- Price: $8.0000
- Deadline: 2025-04-30
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002048576
- Website: https://www.berkshirebiomedical.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2016-07-19
- Address: 5950 BERKSHIRE LN., SUITE 375, DALLAS, TX, 75225
- Employees: 6
Financials (as filed)
- Total assets (most recent): $252K
- Cash (most recent): $90K
- Revenue (most recent): $1.7M
- Revenue (prior): $266K
- Net income (most recent): $-3.1M
- Net income (prior): $-4.9M
- Short-term debt: $177K
- Long-term debt: $8.7M
People (7)
| Name | Role | Location |
|---|
| John Timberlake | President and CEO, and Board Member | Bridgewater, NJ |
| John Timberlake | President & CEO | Bridgewater, NJ |
| John Timberlake | President, CEO, CFO, and Director | Bridgewater, NJ |
| Susan Owen | Director | DALLAS, TX |
| Thomas M Rouse | Board Chair | DALLAS, TX |
| Thomas Rouse | Chairman, Director | DALLAS, TX |
| Thomas Rouse | Chairman of the Board | DALLAS, TX |
Reg CF filing history (5)
More